KEYNOTE SPEAKERS
Giovanni Caforio, MD
Chairman & CEO, Bristol Myers Squibb
Catherine (Katie) Gray, PharmD
Acting Director, FDA Office of Prescription Drug Promotion
Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, HHS OIG
FEATURING CCO FIRESIDE CHAT
Ann E. Beasley, JD
Chief Compliance Officer, Zai Lab
Shefali Kothari, JD
VP, CCO (US), Novartis
Angela Main, JD
SVP, Global CCO & Associate GC, Asia Pacific, Zimmer Biomet
Kristin Rand, JD, MA
Head, Corporate Compliance and Global Risk Officer, Moderna
Latarsha Stewart, JD, MS
VP, Head of Compliance, Servier Pharmaceuticals
PCF EXECUTIVE COMMITTEE
Joe Zimmerman
Vice President, Chief Compliance Officer & Privacy Officer, Ferring Pharmaceuticals, Inc., Parsippany, NJ
(PCF Chair)
“We consulted with our membership and the majority recommended that we hold the Congress again in 2021 as a purely virtual event. Some of our member companies have still not allowed in-person attendance at conferences. Barring unexpected developments, we are currently planning to return to the hybrid model in 2022 which will offer registrants the option of participation onsite or online.”
— PCF Executive Committee
Indrani Franchini, JD
Former Executive Vice President Chief Compliance Officer, Alexion Pharmaceuticals, New York, NY
(PCF Co-Chair)
Joshua Marks, JD
Vice President, Chief Ethics & Compliance Officer, Boehringer Ingelheim, Ridgefield, CT
(PCF Co-Chair)
Margaret Sparks, JD
Head of Compliance, Vaccines, North America Ethics and Business Integrity, Sanofi, Bridgewater, NJ
(PCF Co-Chair)
Ann-Marie Tejcek, MA
Senior Director, Chief Compliance Officer North America, Eli Lilly, Indianapolis, IN
(PCF Co-Chair)
Donna White, CCEP
Vice President, Compliance, Chiesi, USA, Cary, NC
(PCF Co-Chair)
FEATURING THE PHARMA & MEDICAL DEVICE CONGRESS ADVANCED VIRTUAL INTERACTIVE VIDEO BROADCAST PORTAL
Featuring one-on-one attendee video chat and large group video interactive workshops.
See last year’s Congress portal:
